randomized phase iii clinical trial of neoadjuvant intravesical mitomycin c treatment
Published 1 year ago • 302 plays • Length 4:50Download video MP4
Download video MP3
Similar videos
-
3:37
phase iii trial on neoadjuvant intravesical mitomycin c (mmc) treatment for bladder cancer
-
2:12
the rationale behind the phase iii trial on neoadjuvant intravesical mmc treatment of bladder cancer
-
10:46
new treatment of non-muscle-invasive bladder cancer
-
24:39
clinical case - immune check point inhibitor in the perioperative setting for mibc
-
2:24
anzup 1301: mitomycin and bcg in non-muscle-invasive bladder cancer
-
51:32
bladder preservation strategies for mibc - empire urology lecture series
-
1:08:14
urowebinar: bcg unresponsive disease how this definition impact your treatment decision making
-
34:06
the optimization of intravesical chemotherapy for superficial bladder cancer
-
6:42
titan trial
-
20:07
clinical case - extend the benefit of immuno-oncology to more mibc patients: how do we do better?
-
46:05
hivec hr webinar eng
-
0:54
surpass: adp-a2m4cd8 t-cell receptor t-cell therapy and pembrolizumab in uc
-
1:37
preliminary safety results of the mitobcg study in nmibc
-
1:39:37
management of nmibc: practical solutions for common problems
-
5:12
darolutamide for nmcrpc: results of the aramis trial
-
1:59:34
aua2019 023ic: chemotherapy and immunotherapy options for genitourinary malignancies
-
1:02
a randomized trial of photodynamic surgery in non–muscle-invasive bladder cancer
-
5:45
axel s merseburger: mitomycin pyelocalyceal: non-surgical treatment for patients with low-grade utuc